- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Patent holdings for IPC class C12Q 1/6876
Total number of patents in this class: 3631
10-year publication summary
134
|
133
|
279
|
440
|
403
|
468
|
480
|
414
|
449
|
192
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
10X Genomics, Inc. | 1202 |
91 |
Illumina, Inc. | 3340 |
76 |
The Regents of the University of California | 19887 |
71 |
President and Fellows of Harvard College | 5972 |
50 |
Becton, Dickinson and Company | 7254 |
44 |
Natera, Inc. | 320 |
41 |
Prognosys Biosciences, Inc. | 104 |
37 |
University of Washington through its Center for Commercialization | 507 |
35 |
The Board of Trustees of the Leland Stanford Junior University | 6403 |
33 |
The Johns Hopkins University | 5662 |
33 |
Massachusetts Institute of Technology | 10041 |
32 |
Illumina Cambridge Limited | 684 |
32 |
The Broad Institute, Inc. | 1800 |
31 |
Bio-Rad Laboratories, Inc. | 1615 |
30 |
Gen-Probe Incorporated | 993 |
29 |
Life Technologies Corporation | 3290 |
27 |
Cepheid | 339 |
26 |
Singular Genomics Systems, Inc. | 283 |
24 |
F. Hoffmann-La Roche AG | 7930 |
21 |
Regeneron Pharmaceuticals, Inc. | 4252 |
21 |
Other owners | 2847 |